(Q45803207)

English

ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance

scientific article published on 11 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

B Huisamen

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

S J C Pêrel

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

S O Friedrich

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

R Salie

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

H Strijdom

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

A Lochner

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

publication date

11 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

349

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

1-2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

21-31

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

https://scigraph.springernature.com/pub.10.1007/s11010-010-0656-6

0 references

The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Insulin and risk of cardiovascular disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Insulin therapy improves endothelial function in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Cross-talk between the insulin and angiotensin signaling systems

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Insulin in combination with vanadate stimulates glucose transport in isolated cardiomyocytes from obese Zucker rats

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Direct intracellular nitric oxide detection in isolated adult cardiomyocytes: flow cytometric analysis using the fluorescent probe, diaminofluorescein.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Improvement of insulin sensitivity by antagonism of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Up-regulation of Akt and eNOS induces vascular smooth muscle cell differentiation in hypertension in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Cardiac Hypertrophy Is Associated With Decreased eNOS Expression in Angiotensin AT 2 Receptor–Deficient Mice

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0656-6

21 January 2018

Endothelial function: a critical determinant in atherosclerosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide production is higher in rat cardiac microvessel endothelial cells than ventricular cardiomyocytes in baseline and hypoxic conditions: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G alpha i3/Ras/Raf/MAPK pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin receptors and their therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/21153603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-010-0656-6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/21153603

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45803207&oldid=2083276691"